Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Cover Image Credit: Milkos / 123RF.com (Licensed)
How to Transition Off Semaglutide or Tirzepatide Safely Before Pregnancy Consult Your Healthcare Provider Work with your doctor to gradually taper off the medication, if necessary
At consultation we will recommend the product that best fits your area, your tolerance for downtime and your schedule
It does not provide medical advice or determine eligibility for any treatment
A new pathway to access Wegovy for obesity The Medicare GLP-1 Bridge Program is a nationwide, short-term CMS program designed to cover select weight-management drugs for Medicare Part D beneficiaries Medicare GLP-1 Bridge Program Eligible patients can access all doses of Wegovy pill and pen for only Starting July 1, 2026 1 Medicare GLP-1 Bridge Program eligibility 1 Medication prescribed for weight management, in combination with current and ongoing lifestyle modification consistent with the applicable FDA-approved label Enrolled in a Medicare Part D plan (stand-alone PDP or MA PD), including Special Needs Plans (SNPs), employer/union group waiver plans (EGWPs), Limited Income Newly Eligible Transition (LI NET), and dual-eligible beneficiaries who are enrolled in eligible Part D plan types 18 years of age BMI 35 kg/m 2 or BMI 30 kg/m 2 + 1 or more of the following comorbidities Uncontrolled HTN, HFpEF, CKD Stage 3a, or above or BMI 27 kg/m 2 + 1 or more comorbidities Pre-diabetes, previous stroke/MI, symptomatic PAD Terms apply
95% confidence interval [CI], 0.80 to 0.93), myocardial infarction by 13% (HR, 0.87
US$ 21.64
US$ 21.34
US$ 23.11
US$ 25.43
US$ 23.85
